A Network of Investigator Networks in Human Genome Epidemiology Table
ShareCompartir
This website is archived for historical purposes and is no longer being maintained or updated.
TABLE 1: International network-registries in human genome epidemiology
| Field | Network-registry | Type* | No. of teams (no. in thousands)† | Principal contact(s) |
|---|---|---|---|---|
|
Parkinson Disease
|
Genetic Epidemiology of Parkinson Disease (GEO-PD) consortium
|
D (CC>C)
|
18 (10)
|
D. M. Maraganore (dmaraganore@mayo.edu)
|
|
HIV‡ infection
|
International Meta-Analysis of HIV Host Genetics
|
D (C>CC)
|
30 (7)
|
T. R. O’Brien (obrient@exchange.nih.gov)
|
|
Cardiovascular disease
|
Fibrinogen Studies Collaboration and Emerging Risk Factors Collaboration (new genetics component being launched)
|
D (C)
|
50 (200)
|
J. Danesh (john.danesh@phpc.cam.ac.uk)
|
|
Craniofacial anomalies
|
Craniofacial anomalies network developed by the International Collaborative Research on Craniofacial Anomalies Project
|
D (CC)
|
9 (4)
|
J. Little (jlittle@uottawa.ca)
Internet Web address: www.who.int/genomics/anomalies/cfaproject/en/#mtg |
|
Osteoporosis
|
Genetic Markers for Osteoporosis (GENOMOS)
|
D (C>CC)
|
10 (30)
|
A. G. Uitterlinden (a.g.uitterlinden@erasmusmc.nl)
|
|
Antiphospholipid syndrome
|
International Meta-analysis of Antiphospholipid Syndrome Genetics
|
D (CC>C)
|
9 (4)
|
J. P. A. Ioannidis (jioannid@cc.uoi.gr)
|
|
Child growth and metabolism
|
Birth Cohorts Consortium
|
D (C)
|
24 (55)
|
M.-R. Jarvelin (m.jarvelin@imperial.ac.uk)
|
|
Preterm birth
|
Preterm Birth International Collaborative (PREBIC)/Preterm Birth and Genetics International Alliances (PREGENIA)
|
D (C, CC)
|
10 (20)
|
S. Dolan (sdolan@marchofdimes.com)
|
|
Cancer, cardiovascular diseases, diabetes, aging
|
European Prospective Investigation on Cancer, chronic diseases and nutrition (EPIC)
|
D, E (C)
|
521 (120)
|
E. Riboli (riboli@iarc.fr)
|
|
Lymphoma
|
International Lymphoma Epidemiology Consortium (InterLymph)
|
D (CC>C)
|
15 (20)
|
P. Hartge (ph43v@nih.gov), P. Boffetta (boffetta@iarc.fr)
|
|
Lung cancer
|
International Lung Cancer Consortium (ILCCO)
|
D (CC>C)
|
30 (51)
|
R. Hung (hung@iarc.fr)
|
|
Head and neck cancer
|
International Head and Neck Cancer Consortium (INHANCE)
|
D (CC)
|
13 (28)
|
M. Hashibe (hashibe@iarc.fr)
|
|
Melanoma
|
Melanoma Genetics Consortium (GenoMel)
|
D (CC)
|
12 (3)
|
J. A. Newton Bishop (j.newton-bishop@cancer.org.uk); Internet Web address: www.genomel.org
|
|
Pancreatic cancer
|
Pancreatic Cancer: Genetic Epidemiology (PACGENE) Consortium
|
D (CC)
|
10 (5)
|
G. Petersen (peterg@mayo.edu)
|
|
Breast cancer and prostate cancer
|
Breast and Prostate Cancer and Hormone- Related Variants Cohort Consortium
|
D (C)
|
6 (13 + 20)
|
D. Hunter (dhunter@hsph.harvard.edu)
|
|
Brain tumors
|
Brain Tumor Epidemiology Consortium (BTEC)
|
D (CC)
|
22
|
M. Bondy (mbondy@mdanderson.org), B. Malmer (beatrice.malmer@onkologi.umu.se)
|
|
Breast cancer and colon cancer
|
Breast and Colon Cancer Family Registries
|
D
|
10 (34 + 30)
|
I. L. Andrulis, N. M. Lindor (seminard@mail.nih.gov
|
|
Cancer
|
Cancer Genetics Network (CGN)/Informatics Technology Group
|
D (C)
|
8 (24)
|
C. Kasten (seminard@mail.nih.gov)
|
|
Radiation and breast cancer
|
Women’s, Environmental, Cancer, and Radiation Epidemiology (WECARE) Study Consortium
|
E (CC)
|
15 (2)
|
J. Bernstein (bernstej@mskcc.org)
|
|
Environmental carcinogens
|
International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens (GSEC)
|
E (CC)
|
130 (58)
|
E. Taioli (taioli@policlinico.mi.it)
|
|
Assisted reproduction
|
International Pooled Analysis of Children Born after Assisted Procedures (APIKIDS)
|
E (C)
|
6 (7)
|
E. Taioli (taioli@policlinico.mi.it)
|
|
DNA repair genes and cancer
|
Web-based meta-analysis on DNA repair and cancer risk
|
G (CC>C)
|
5
|
P. Vineis (p.vineis@imperial.ac.uk)
|
|
Other cancer-related networks
|
D, G (C/CC)
|
|||
|
Proposals for other networks
|
Human Genome Epidemiology Network (HuGENet™)
|
* D, disease-based network; CC>C, mostly case-control but also cohort studies included; C>CC, mostly cohort but also case-control studies included; C, cohort studies included; CC, case-control studies included; E, exposure-based network; G, gene-based network.
† In determining the number of teams, multicenter teams counted as one team, and the number of investigators may be much larger; numbers in parentheses show the approximate total number of subjects in the compiled databases.
‡ HIV, human immunodeficiency virus.
- Page last reviewed: July 21, 2009 (archived document)
- Content source: